(Q30787765)

26 June 2017

title

Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful or beneficial? (English)

1 reference

26 June 2017

Inflammatory Reaction in Progressive Multifocal Leukoencephalopathy: Harmful or Beneficial? (English)

1 reference

10.1080/13550280390195315

Crossref

DOI

https://api.crossref.org/works/10.1080/13550280390195315

progressive multifocal leukoencephalopathy

26 December 2023

main subject

0 references

1 reference

10.1080/13550280390195315

https://api.crossref.org/works/10.1080/13550280390195315

26 December 2023

1

Renaud A. Du Pasquier

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12709868

26 December 2023

author name string

Igor J. Koralnik

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12709868

26 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12709868

26 December 2023

publication date

1 January 2003

1 reference

26 June 2017

published in

Journal of NeuroVirology

1 reference

26 June 2017

volume

9 Suppl 1

1 reference

26 June 2017

page(s)

25-31

1 reference

JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.

26 June 2017

cites work

1 reference

12 December 2020

JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy

1 reference

12 December 2020

Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy

1 reference

12 December 2020

AIDS- and non-AIDS-related PML association with distinct p53 polymorphism

1 reference

12 December 2020

Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy

1 reference

12 December 2020

The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy.

1 reference

12 December 2020

Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoencephalopathy

1 reference

12 December 2020

Subclinical Central Nervous System Infection with JC Virus in Patients with AIDS

1 reference

12 December 2020

Detection of JC virus DNA in peripheral blood cell subpopulations of HIV-1-infected individuals

1 reference

12 December 2020

HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy

1 reference

12 December 2020

Enhancing progressive multifocal leukoencephalopathy: an indicator of improved immune status?

1 reference

12 December 2020

Prognostic value of JC virus load in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy

1 reference

12 December 2020

Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy.

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy following initiation of highly active antiretroviral therapy

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy: three patients diagnosed by brain biopsy, with prolonged survival in two.

1 reference

12 December 2020

Contrast-enhancing progressive multifocal leukoencephalopathy as an immune reconstitution event in AIDS patients

1 reference

12 December 2020

Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy.

1 reference

12 December 2020

Initial and follow-up MR imaging findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active antiretroviral therapy.

1 reference

12 December 2020

The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy.

1 reference

12 December 2020

Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era.

1 reference

12 December 2020

Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope.

1 reference

12 December 2020

Immunorestitution disease involving the innate and adaptive response

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy in patients with human immunodeficiency virus

1 reference

12 December 2020

Prolonged progressive multifocal leukoencephalopathy without immunosuppression.

1 reference

12 December 2020

Atypical progressive multifocal leukoencephalopathy with plasma-cell infiltrates

1 reference

12 December 2020

JC virus regulatory region tandem repeats in plasma and central nervous system isolates correlate with poor clinical outcome in patients with progressive multifocal leukoencephalopathy

1 reference

12 December 2020

JC virus detection by in situ hybridization in brain tissue from elderly patients

1 reference

12 December 2020

Images in neurology. Mass effect in progressive multifocal leukoencephalopathy

1 reference

12 December 2020

1 reference

12 December 2020

Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy

1 reference

12 December 2020

10.1080/13550280390195315

Identifiers

DOI

0 references

Dimensions Publication ID

1033931256

0 references

1 reference